Physician profile
Ying Yang
NPI 1639328032
$6,573.19
in general payments reported to CMS, 2019-2025
29 companies · $2,335 in 2025
The $2,335 reported for 2025 was more than what 95% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $591 · 2022: $487 · 2023: $1,202 · 2024: $1,958 · 2025: $2,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,392 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,391.81 |
| Education | $103.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,203.72 | 2021-2025 | |
| Janssen Biotech, INC. | $1,022.92 | 2021-2025 | Tremfya |
| Ucb, INC. | $700.34 | 2021-2025 | Bimzelx, Cimzia |
| Sun Pharmaceutical Industries INC. | $449.94 | 2021-2025 | Ilumya, Winlevi, Absorica Ld |
| Novartis Pharmaceuticals Corporation | $435.82 | 2021-2025 | |
| Incyte Corporation | $330.63 | 2022-2025 | Opzelura |
| Genzyme Corporation | $286.62 | 2022-2025 | |
| Amgen INC. | $247.76 | 2023-2025 | Otezla, Otezla |
| Leo Pharma INC. | $233.11 | 2021-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $214.96 | 2021-2025 | Libtayo, Dupixent |
| E.R. Squibb & Sons, L.L.C. | $194.66 | 2022-2025 | Sotyktu |
| Dermavant Sciences, INC. | $188.84 | 2023-2024 | Vtama |
| Galderma Laboratories, L.P. | $146.21 | 2021-2025 | Nemluvio, Aklief |
| Pfizer INC. | $142.66 | 2021-2024 | |
| Convatec INC. | $138.66 | 2024-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $125.00 | 2023 | Vemlidy |
| Verrica Pharmaceuticals INC. | $80.28 | 2023-2025 | Ycanth |
| Organon LLC | $71.38 | 2025 | Nexplanon, Vtama |
| Lilly USA, LLC | $67.01 | 2021-2024 | Taltz, Zepbound |
| Arcutis Biotherapeutics, INC. | $65.20 | 2023-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $58.11 | 2021-2025 | Cabtreo |
| Almirall LLC | $36.14 | 2025 | Klisyri |
| Blueprint Medicines Corporation | $24.75 | 2024 | Ayvakit |
| Kerecis Limited | $24.63 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Kyowa Kirin, INC. | $24.25 | 2024 | Poteligeo |
| Strata Skin Sciences, INC. | $15.90 | 2025 | Xtrac |
| Helsinn Therapeutics (U.S.), INC. | $15.21 | 2022 | |
| Journey Medical Corporation | $15.09 | 2023 | |
| Epi Health, LLC | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ying Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.